// App-Quantinova.ai

416.0 : Prognostic factors associated with long term survival in chemotherapy-treated advanced pancreatic cancer: A Canadian multicenter analysis.

Researchers

Presenter

  • Christina Kim

Principal Investigators

  • Shahid Ahmed

  • Dawn Elizabeth Armstrong

  • Tayyba Baig

  • Miguel Cardoso

  • Yoo-Joung Ko

  • Shiying Kong

  • Madison Mackinnon

  • Brandon Matthew Meyers

  • Michelle Pratt

  • Julie Ward

  • Yuan Xu

  • Winson Y. Cheung

Medical Centers

  • Cancer Care Manitoba, Winnipeg, MB, Canada

  • University of Saskatchewan, Saskatoon, SK, Canada

  • Dr. H. Bliss Murphy Cancer Centre, St John's, NF, Canada

  • Juravinski Cancer Centre, Burlington, ON, Canada

  • Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • Alberta Health Services, Calgary, AB, Canada

  • Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • Juravinski Cancer Centre and McMaster University, Hamilton, ON, Canada

  • Dr. H. Bliss Murphy Cancer Centre, St John's, NF, Canada

  • Cancer Care Manitoba, Winnipeg, MB, Canada

  • University of Calgary, Calgary, AB, Canada

  • Tom Baker Cancer Center - University of Calgary, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreato-biliary malignancies

Biomarkers

  • Adenomatous Polyposis Coli

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A